How has been the historical performance of Ajooni Biotech?

Answer:The historical performance of Ajooni Biotech shows significant growth in net sales and profitability over the years. Breakdown: Ajooni Biotech's net sales have increased from 39.72 Cr in Mar'19 to 114.69 Cr in Mar'25, reflecting a strong upward trend. Total operating income has similarly risen, reaching 114.69 Cr in Mar'25 from 40.06 Cr in Mar'19. The company's total expenditure has also grown, but at a slower pace, leading to an operating profit (PBDIT) of 5.75 Cr in Mar'25, up from 0.89 Cr in Mar'19. Profit before tax has improved significantly, reaching 4.33 Cr in Mar'25 compared to 0.47 Cr in Mar'19, while profit after tax has increased to 3.37 Cr from 0.41 Cr in the same period. The company's equity capital has more than doubled from 6.16 Cr in Mar'19 to 34.45 Cr in Mar'25, and total assets have grown from 22.94 Cr to 94.67 Cr. However, the company has seen fluctuations in cash flow, with a net cash outflow of 10.00 Cr in Mar'25, contrasting with a net inflow of 26.00 Cr in Mar'24. Overall, Ajooni Biotech has demonstrated robust growth in sales and profitability, although cash flow management remains a challenge.